Consumer healthcare giant Johnson & Johnson (J&J) has confirmed that it was pulling some versions of infant Tylenol off store shelves in the United States due to problems with new design of the bottles.
The company said it would recall all of the 574,000 redesigned bottles of grape-flavored liquid infant Tylenol.
The redesigned bottles of infant Tylenol included a plastic cover that was designed to make it easier for parents to extract the correct dose of the medicine with a plastic syringe.
But some parents complained that when they slotted the syringe into the top of the bottle, it shoved the cover right into the bottle, making it complicated to gauge the right quantity of the medicine.
Chief executive William Weldon claimed that was nothing incorrect with the medicine itself and that the company issued the latest recall to preserve and reinforce the company’s commitment to patients and consumers.
Since 2009, J&J has issued several recalls, pulling millions of bottles of Tylenol, Benadryl and Motrin off the store shelves due to problems such as metal shavings found in medicines, bad odors and wrong levels of an active ingredient.
- Finally a $7 Billion Settlement for Citigroup
- Discussions In Progress for Merger of Tobacco Businesses: Reynolds to Acquire Lorillard
- Amazon Seeks Permission to Fly Drones for Delivery of Packages from FAA
- Wells Fargo Reports a Profit
- Abbott hits JV deal with Fonterra to operate diary farms in China